Related Experiment Videos
Neuropsychological performance in HIV/AIDS intravenous drug users
E Vazquez-Justo1, M Rodríguez Alvarez, J Carro Ramos
1Department of Clinical Psychology and Psychobiology, University of Santiago de Compostela, Spain.
Journal of Clinical and Experimental Neuropsychology
|September 19, 2003
Summary
HIV infection in intravenous drug users is linked to significant neuropsychological deficits. These cognitive and motor impairments are distinct from those caused by drug abuse alone, indicating a dual impact.
Area of Science:
- Neuroscience
- Infectious Diseases
- Psychology
Background:
- Human Immunodeficiency Virus (HIV) can directly infect the Central Nervous System (CNS).
- HIV-associated CNS infection can lead to neuropsychological alterations affecting cognition, behavior, and motor function.
Purpose of the Study:
- To determine if HIV seropositivity is associated with poorer neuropsychological performance in individuals with a history of intravenous drug consumption.
- To differentiate the effects of HIV seropositivity from the effects of a history of drug abuse on neuropsychological outcomes.
Main Methods:
- An extensive neuropsychological evaluation was conducted on HIV-seropositive intravenous drug users (n=90).
- Performance was compared to two seronegative control groups: one with no drug abuse history (n=22) and one with a drug abuse history (n=48).
Main Results:
- HIV infection in drug users was associated with significant deficits in attention, memory (verbal and visual), verbal skills, concept formation, reasoning, visual-constructive skills, manual dexterity, and perceptive-motor speed.
- These deficits were not solely attributable to a history of drug abuse.
- Seronegative drug users also exhibited some alterations, suggesting that HIV seropositivity exacerbates existing impairments.
Conclusions:
- HIV infection significantly contributes to neuropsychological deficits in drug users, beyond the effects of drug abuse.
- Seropositivity exacerbates cognitive and motor impairments observed in seronegative drug users, highlighting the dual pathology of HIV and substance abuse.